Alimera Sciences (ALIM) Reports In-Line Q3 EPS

Alimera Sciences (NASDAQ: ALIM) reported Q3 EPS of ($0.21), in-line with the analyst estimate of ($0.21). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $6.96 million.

For earnings history and earnings-related data on Alimera Sciences (ALIM) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance